In this regard, compromised hepatic insulin extraction has been shown to constitute a risk factor for obesity (66, 67), type 2 diabetes (68), metabolic syndrome (65, 69), and fatty liver disease (70). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.